BlackRock Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$217K Buy
6,729
+1,155
+21% +$29.6K ﹤0.01% 2637
2016
Q3
$146K Buy
5,574
+495
+10% +$13K ﹤0.01% 2729
2016
Q2
$117K Buy
+5,079
New +$126K ﹤0.01% 2746
2015
Q4
Sell
-7,924
Closed -$139K 3061
2015
Q3
$139K Hold
7,924
﹤0.01% 2623
2015
Q2
$143K Buy
7,924
+1,802
+29% +$24.6K ﹤0.01% 2668
2015
Q1
$76K Hold
6,122
﹤0.01% 2705
2014
Q4
$72K Buy
+6,122
New +$71.3K ﹤0.01% 2731

Other funds holding LOXO

BlackRock Group's LOXO Position: Q4 2016 in Review

BlackRock Group increased its Loxo Oncology, Inc (LOXO) stake by 21% in Q4 2016, buying an estimated $29.6K and bringing the position to 6,729 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

BlackRock Group first reported a position in LOXO in Q4 2014 and has held it in 7 quarters since. 86 funds tracked by Wall St. Rank hold LOXO as of Q4 2016.

  • BlackRock Group held 6,729 shares of Loxo Oncology, Inc worth $217K as of Q4 2016.
  • BlackRock Group bought 1,155 Loxo Oncology, Inc shares in Q4 2016, an estimated $29.6K.
  • Loxo Oncology, Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2637 holding.
  • BlackRock Group first reported a position in Loxo Oncology, Inc in Q4 2014 and has held it in 7 quarters since.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.